Testing effectiveness (Phase 2)Study completedNCT01801449
What this trial is testing
Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)
Who this might be right for
DIRA
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 6